Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Frega

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|December 30, 2025
Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New PerspectivesMartina Astore, Laura Fabbri, Andrea Monte, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical CenterAlessandro Rizzo, Riccardo Carloni, Giorgio Frega, et al.
Cancers|October 26, 2024
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic ImplicationsAngela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Frontiers in Oncology|April 2, 2025
Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinomaChiara Deiana, Andrea Palloni, Mirta Mosca, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 28, 2020
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future ChallengesAlessandro Rizzo, Alessandro Di Federico, Angela Dalia Ricci, et al.
Future Oncology (London, England)|July 12, 2017
Postsorafenib systemic treatments for hepatocellular carcinoma: questions and opportunities after the regorafenib trialFrancesco Tovoli, Stefania De Lorenzo, Maria Aurelia Barbera, et al.
Future Oncology (London, England)|February 3, 2022
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand?Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, et al.
Scientific Reports|July 4, 2018
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of conceptStefania De Lorenzo, Francesco Tovoli, Maria Aurelia Barbera, et al.
In Vivo (Athens, Greece)|July 2, 2020
How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysisAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.
Cancers|November 7, 2020
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and FailuresAlessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|December 30, 2025
Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New PerspectivesMartina Astore, Laura Fabbri, Andrea Monte, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical CenterAlessandro Rizzo, Riccardo Carloni, Giorgio Frega, et al.
Cancers|October 26, 2024
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic ImplicationsAngela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Frontiers in Oncology|April 2, 2025
Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinomaChiara Deiana, Andrea Palloni, Mirta Mosca, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 28, 2020
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future ChallengesAlessandro Rizzo, Alessandro Di Federico, Angela Dalia Ricci, et al.
Future Oncology (London, England)|July 12, 2017
Postsorafenib systemic treatments for hepatocellular carcinoma: questions and opportunities after the regorafenib trialFrancesco Tovoli, Stefania De Lorenzo, Maria Aurelia Barbera, et al.
Future Oncology (London, England)|February 3, 2022
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand?Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, et al.
Scientific Reports|July 4, 2018
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of conceptStefania De Lorenzo, Francesco Tovoli, Maria Aurelia Barbera, et al.
In Vivo (Athens, Greece)|July 2, 2020
How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysisAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.
Cancers|November 7, 2020
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and FailuresAlessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, et al.
Pageof 6